v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses:        
Research and development $ 23,768 $ 27,217 $ 51,379 $ 49,336
Selling, general and administrative 21,925 15,640 38,093 31,324
Total operating expenses 45,693 42,857 89,472 80,660
Loss from operations (45,693) (42,857) (89,472) (80,660)
Other income, net:        
Interest income 2,323 1,960 4,893 4,191
Other expense, net (53) (546) (128) (881)
Total other income, net 2,270 1,414 4,765 3,310
Net loss $ (43,423) $ (41,443) $ (84,707) $ (77,350)
Net loss per share - basic $ (0.39) $ (0.46) $ (0.76) $ (0.88)
Net loss per share - diluted $ (0.39) $ (0.46) $ (0.76) $ (0.88)
Weighted-average shares used in computing net loss per share - basic 111,196,883 89,138,568 110,881,872 87,427,345
Weighted-average shares used in computing net loss per share - diluted 111,196,883 89,138,568 110,881,872 87,427,345